Duration of clopidogrel treatment and risk of mortality and recurrent myocardial infarction among 11 680 patients with myocardial infarction treated with percutaneous coronary intervention: a cohort study
-
* Corresponding author: Rikke Sørensen rs@heart.dk
1 Department of Cardiology, Copenhagen University Hospital Gentofte, Niels Andersens Vej 65, 2900 Hellerup, Denmark
2 Cardiovascular Research Unit, Department of Internal Medicine, Copenhagen University Hospital Glostrup, Ndr. Ringvej 57, 2600 Glostrup, Denmark
3 National Institute of Public Health, University of Southern Denmark, Øster Farimagsgade 5A, second floor, 1353 København K, Denmark
4 The Heart Centre, Copenhagen University Hospital Rigshospitalet, Blegdamsvej 9, 2100 København Ø, Denmark
5 Department of Clinical Pharmacology, Copenhagen University Hospital Bispebjerg, Bispebjerg Bakke 23, 2400 København NV, Denmark
6 Laboratory of Clinical Pharmacology, Q7642, Copenhagen University Hospital Rigshospitalet, Blegdamsvej 9, 2100 København Ø, Denmark
BMC Cardiovascular Disorders 2010, 10:6 doi:10.1186/1471-2261-10-6
Published: 29 January 2010Additional files
Additional file 1:
Baseline characteristics. This file contains baseline information (year of admission, sex, age, co-morbidity, concomitant medical treatment). The patients are stratified according to PCI status.
Format: PDF Size: 11KB Download file
This file can be viewed with: Adobe Acrobat Reader
